Genzyme Europe
Health Care Professionals
Health Care Professionals
Products Approved under the Centralised Procedure
This table contains information for the Genzyme products which have been granted Marketing Authorisation by the European Commission through the Centralised (or ‘Community’) procedure. These marketing authorisations are valid in all European Union (EU) and EEA-EFTA states (Iceland, Liechtenstein and Norway). Due to the nature of this authorisation, information regarding these products is harmonised across these markets. These links point to the English language version, but identical product information is available within each market in the national languages of these countries. However Genzyme Europe is also the Marketing Authorisation Holder for several other products which are either medical devices or have been authorised under national or mutual recognition procedures. Because the labelling and use of these products can vary from one member state to another the English language product information is not representative for all member states, and is not presented here.